Academic literature on the topic 'CD antigens'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'CD antigens.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "CD antigens"

1

Woolfson, Adrian, Justin Stebbing, Brian D. M. Tom, Kerryn J. Stoner, Walter R. Gilks, David P. Kreil, Stephen P. Mulligan, et al. "Conservation of unique cell-surface CD antigen mosaics in HIV-1–infected individuals." Blood 106, no. 3 (August 1, 2005): 1003–7. http://dx.doi.org/10.1182/blood-2004-12-4642.

Full text
Abstract:
AbstractCluster of differentiation (CD) antigens are expressed on cells of myeloid and lymphoid lineages. As most disease processes involve immune system activation or suppression, these antigens offer unique opportunities for monitoring host responses. Immunophenotyping using limited numbers of CD antigens enables differentiation states of immune system cells to be determined. Extended phenotyping involving parallel measurement of multiple CD antigens may help identify expression pattern signatures associated with specific disease states. To explore this possibility we have made a CD monoclonal antibody array and scanner, enabling the parallel immunophenotyping of leukocyte cell suspensions in a single and rapid analysis. To demonstrate this approach, we used the specific example of patients infected with human immunodeficiency virus type-1 (HIV-1). An invariant HIV-induced CD antigen signature has been defined that is both robust and independent of clinical outcome, composed of a unique profile of CD antigen expression levels that are both increased and decreased relative to internal controls. The results indicate that HIV-induced changes in CD antigen expression are disease specific and independent of outcome. Their invariant nature indicates an irreversible component to retroviral infection and suggests the utility of CD antigen expression patterns in other disease settings.
APA, Harvard, Vancouver, ISO, and other styles
2

Mason, David, Pascale André, Armand Bensussan, Chris Buckley, Curt Civin, Edward Clark, Masja de Haas, et al. "CD antigens 2001." Journal of Leukocyte Biology 70, no. 5 (November 2001): 685–90. http://dx.doi.org/10.1189/jlb.70.5.685.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kishimoto, T., S. Goyert, H. Kikutani, D. Mason, M. Miyasaka, L. Moretta, T. Ohno, et al. "CD Antigens 1996." Blood 89, no. 10 (May 15, 1997): 3502. http://dx.doi.org/10.1182/blood.v89.10.3502.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kishimoto, T., S. Goyert, H. Kikutani, D. Mason, M. Miyasaka, L. Moretta, T. Ohno, et al. "CD Antigens 1996." Blood 89, no. 10 (May 15, 1997): 3502. http://dx.doi.org/10.1182/blood.v89.10.3502.3502_3502_3502.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Schlossman, SF, L. Boumsell, W. Gilks, JM Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, RL Silverstein, and TA Springer. "CD antigens 1993." Blood 83, no. 4 (February 15, 1994): 879–80. http://dx.doi.org/10.1182/blood.v83.4.879.879.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Schlossman, SF, L. Boumsell, W. Gilks, JM Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, RL Silverstein, and TA Springer. "CD antigens 1993." Blood 83, no. 4 (February 15, 1994): 879–80. http://dx.doi.org/10.1182/blood.v83.4.879.bloodjournal834879.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Schlossman, S. F., L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, et al. "CD Antigens 1993." Leukemia & Lymphoma 13, sup1 (January 1994): 59–60. http://dx.doi.org/10.3109/10428199409052676.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mason, D. Y., P. André, A. Bensussan, C. Buckley, C. Civin, E. Clark, M. De Haas, et al. "CD antigens 2001." Tissue Antigens 58, no. 6 (December 2001): 425–30. http://dx.doi.org/10.1034/j.1399-0039.2001.580614.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mason, David, Pascale André, Armand Bensussan, Chris Buckley, Curt Civin, Edward Clark, Masja de Haas, et al. "CD Antigens 2001." Modern Pathology 15, no. 1 (January 2002): 71–76. http://dx.doi.org/10.1038/modpathol.3880492.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Knapp, W., B. Dorken, P. Rieber, RE Schmidt, H. Stein, and AE von dem Borne. "CD antigens 1989." Blood 74, no. 4 (September 1, 1989): 1448–50. http://dx.doi.org/10.1182/blood.v74.4.1448.1448.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "CD antigens"

1

Osorio, Fernández Lyda María. "Regulation of T-cell proliferation and B-CLL apoptosis by CD6 and FAS/FASL /." Stockholm, 1998. http://diss.kib.ki.se/search/diss.se.cfm?19980605osor.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fernvik, Eva C. "Cell biological mechanisms and activity markers of eosinophils in relation to allergic inflammation /." Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3399-5/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Varelias, Antiopi. "Studies of CD44 variant isoform expression and function on activated human peripheral blood mononuclear cells and in renal transplantation." Title page, summary and contents only, 2001. http://web4.library.adelaide.edu.au/theses/09PH/09phv293.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Walter, Roland Bruno. "Mechanism of endocytosis of CD33/Siglec-3 : role of ITIMs, tyrosine phosphorylation, and monoubiquitylation /." Thesis, Connect to this title online; UW restricted, 2006. http://hdl.handle.net/1773/6325.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Otipoby, Kevin L. "CD22 regulates B cell fate via two signaling domains within its cytoplasmic tail /." Thesis, Connect to this title online; UW restricted, 2000. http://hdl.handle.net/1773/8335.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Misztela, Dominika. "The differential effects of CD80 and CD86 in helper T lymphocyte activation." Thesis, University of Oxford, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.670088.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cheung, Chi-ho, and 張志豪. "Identification of CD47 as a novel therapeutic target for hepatocellular carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46945374.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Dai, Tong. "Differential role of CEACAM1 and CEACAM2 in insulin metabolism." Connect to full-text via OhioLINK ETD Center, 2004. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=mco1139336269.

Full text
Abstract:
Thesis (Ph.D.)--Medical University of Ohio, 2004.
"In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Medical Sciences." Major advisor: Sonia M. Najjar. Includes abstract. Document formatted into pages: v, 217 p. Title from title page of PDF document. Bibliography: pages 158-216.
APA, Harvard, Vancouver, ISO, and other styles
9

Haas, Karen M. "Induction and regulation of bovine B lymphocyte responses." free to MU campus, to others for purchase, 2000. http://wwwlib.umi.com/cr/mo/fullcit?p9999290.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Daoud, Roni N. "A study of MRP1-drug interactions : identification of the drug binding site(s)." Thesis, McGill University, 2000. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=36801.

Full text
Abstract:
Over-expression of either P-gp1 and/or MRP1 in tumor cell lines confers resistance to structurally diverse anti-cancer drugs. Although the role of these two proteins in clinical drug resistance remains to be confirmed, the use of Pgp1-specific inhibitors in combination with standard anti-cancer drugs have demonstrated significant improvement in clinical response. However, evidence exists that reversal of P-gp1 alone is not sufficient. Therefore, while no drugs are currently available that can efficiently reverse MRP1 drug efflux in tumor cells, there is an urgent need to develop MRP1-specific blockers. In an effort to gain a better understanding of MRP1-drug interactions and to identify sequences within MRP1 that interact directly with drugs, we developed two structurally diverse photosensitive drug analogues, a quinoline-based compound (IACI) and a xanthone-derivative (IAARh123). Both compounds photolabeled MRP1 and showed a direct and specific interaction with the protein at physiologically relevant sites. Initial mapping of photolabeled sequences in MRP1 (Chapters 2 and 3), identified multiple IACI- or IAARh123-photolabeled peptides (∼4--7 kDa) derived from both the N-terminal (MSD0+MSD1+NBD 1) and C-terminal (MSD2+NBD2) domains of MRP1. A subsequent study (Chapter 4), using MRP1 variants with hemagglutinin (HA) epitopes inserted at eight different locations, led to a higher resolution mapping of the previously identified IACI- or IAARh123-labeled peptides. Specifically, two photolabeled peptides (∼6--7 kDa), derived from variants with insertions at positions 574 and 1222, were immunoprecipitated with anti-HA monoclonal antibody. Based on the location of the HA epitopes in the latter variants together with molecular masses of the two peptides, the photolabeled amino acid residues were localized to MRP1 sequences encoding transmembranes 10 and 11 of MSD1 and transmembranes 16 and 17 of MSD 2. Interestingly, the same sequences were photolabeled with both
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "CD antigens"

1

Kapil, Mehta, and Malavasi Fabio, eds. Human CD38 and related molecules. Basel: Karger, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

name, No. Ectopeptidases: CD13/aminopeptidase N and CD26/dipeptidylpeptidase IV in medicine and biology. New York, NY: Kluwer Academic/Plenum, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lieping, Chen, ed. The B7-CD28 family molecules. Georgetown, Tex: Landes Bioscience/Eurekah.com, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

S, Jack Robert, ed. CD14 in the inflammatory response. Basel: Karger, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

1953-, Gordon J., ed. CD23--a novel multifunctional regulator of the immune system that binds IgE. Basel: Karger, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Okudela, Koji. Cancer stem cells in lung cancer. Hauppauge, N.Y: Nova Science Publishers, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

1943-, Wunder E. W., ed. Hematopoietic stem cells: The Mulhouse manual. Dayton, Ohio, USA: AlphaMed Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chen, Lieping. CD137 Pathway: Immunology and Diseases. Springer, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chen, Lieping. CD137 Pathway: Immunology and Diseases. Springer, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Chen, Lieping. CD137 Pathway: Immunology and Diseases. Springer London, Limited, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "CD antigens"

1

Christopherson, Richard I. "CD Antigens." In Encyclopedia of Cancer, 1–6. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_947-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Christopherson, Richard I. "CD Antigens." In Encyclopedia of Cancer, 842–46. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-46875-3_947.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ward, Tony Milford. "CD Antigens (Soluble)." In Proteins and Tumour Markers May 1995, 1001–9. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0681-8_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kropshofer, Harold, Claudia Müller, and Hubert Kalbacher. "Fluorescence and CD-spectrometric use of specifically labeled peptide antigens interacting with HLA-DR 1." In Peptides 1990, 892–94. Dordrecht: Springer Netherlands, 1991. http://dx.doi.org/10.1007/978-94-011-3034-9_366.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gorga, Joan C., Aichun Dong, Mark C. Manning, Robert W. Woody, Winslow S. Caughey, and Jack L. Strominger. "Comparison of the Secondary Structures of Human Class I and Class II MHC Antigens by Ftir and CD Spectroscopy." In Protein Structure and Engineering, 355–65. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4684-5745-2_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Żeromski, Jan, Renata Jenek, Zofia Niemir, and Wlodzimierz Liebert. "CD 56 (N-CAM) antigen and mRNA expression in human endocrine glands." In Advances in Experimental Medicine and Biology, 335–39. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-0685-0_47.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Majer, Zs, S. Holly, G. K. Tóth, Gy Váradi, I. Laczkó, É. Rajnavölgyi, and M. Hollósi. "Conformational mapping of the antigenic intersubunit region of influenza virus hemagglutinin: CD and FTIR spectroscopy studies." In Peptides 1994, 545–46. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-1468-4_247.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hołowiecki, J., D. Lutz, S. Krzemień, F. Graf, G. Keleney, M. Brugiatelli, V. Callea, et al. "Expression of CD-15 Antigen on Leukemic Cells — A New Prognostic Factor for Ability to Achieve Complete Remission and for Survival in ANLL." In Acute Leukemias, 361–64. Berlin, Heidelberg: Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71213-5_59.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Stockinger, Hannes, Otto Majdic, and Walter Knapp. "CD Antigens." In Encyclopedia of Immunology, 444–57. Elsevier, 1998. http://dx.doi.org/10.1006/rwei.1999.0118.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

"CD Antigens." In Immunology, Infection, and Immunity, 667–74. Washington, DC, USA: ASM Press, 2015. http://dx.doi.org/10.1128/9781555816148.app1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "CD antigens"

1

Wernet, P., E. M. Scheider, P. Sarin, P. Chandra, H. H. Brackmann, M. Kessler, and H. Egli. "Demonstration of HIV-encoded Proteins in Cultured and in Uncultured CD 4 Positive Mononuclear Cells from Hemophilia Patients Employing Monoclonal Antibodies against p 15, p 24, GP 41, GP 120, and Reverse Transcriptase." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644683.

Full text
Abstract:
In the light of the large percentage of hemophilia patients with antibodies to HIV the identification of a specific virus infection in comparison to HIV antibody negative hemophilia patients has reached crucial importance. The low success rates of direct virus culture techniques together with the as yet low AIDS-di-sease rate observed in these patients separate these patients from the other main risk groups. Within this context, we studied the expression of CD3, CD4, CD8, and HLA class II antigens on fixed cells after PHA stimulation and Interleukin 2 propagation as well as on untreated blood mononuclear cells from healthy individuals and from hemophilia patients by fluorescence activated flow cytometry. Monoclonal antibodies thought to be specific for p 15, p 24, GP 41, GP 120, and for reverse transcriptase revealed a certain number of positive cells on all defined subpopulations analysed. From cell specimen of HIV antibody positive hemophilia patients cells with specific HIV antigens could be enriched by in vitro cultivation. Importantly the expression of virus-encoded antigens preceedes a cytopathic effect for several daVs. Current analyses aim at the prognostic relevance of low amounts of such viral HIV proteins selectively detectable by moAbs.directed to either p 24, GP 41, GP 120, and RT. The reliability, high sensitivity and monoclonal antibody dependent specificity of this newly developed method for the demonstration of HIV specific proteins make it applicable also for longitudinal surveys of hemophilia patients to assess a potential state of viremia or virus antigen processing in their mononuclear cells.
APA, Harvard, Vancouver, ISO, and other styles
2

Nagata, H., S. Nomura, K. Oda, T. Kokawa, and K. Yasunaga. "ANALYSIS OF THE FUNCTIONAL ROLE OF PLATELET MEMBRANE GLYCOPROTEINS WITH MONOCLONAL ANTIBODIES." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643509.

Full text
Abstract:
Eight monoclonal antibodies were obtained which recognized platelet surface antigens of these, 5 (NNKYl-32, NNKY2-5, NNKY2-6, NNKY2-11, NNKY2-18 ) recognized GP IIb-IIIa complex, 2 (NNKY5-4, NNKY5-5 ) recognized GP lb and 1 (NNKYl-19) recognized CD 9 antigen. They were used to research the platelet membrane antigens.Monoclonal antibodies that recognize CD 9 antigen, which exists on the surface of platelets, acute lymphoblastic leukemia cells, eosinophils and other tissue, are known to act as an aggregating agent to platelets and NNKYl-19 was fond to induce platelet aggregation accompanied by ATP release. NNKY5-4 had no effect on platelet functions. NNKY5-5 inhibited aggregation induced by ristocetin but had no effect on aggregation induced by ADP, collagen, thrombin, and NNKYl-19. NNKYl-32, 2-5, 2-6, 2-11, and 2-18 inhibited aggregation induced by ADP, collagen, thrombin, and NNKYl-19, although slight release of ATP was recognized when NNKYl-19-induced aggregation was completely inhibited by NNKYl-32. Mutual inhibition of binding to platelet membranes between the 3 groups of monoclonal antibodies was not recognizedNNKYl-19-induced aggregation was associated with a lag time that was plo-longed in inverse proportion to antibody concentration. Aspirin had almost no effect on NNKYl-19-induced aggregation. A TXA2 receptor antagonist, a calci-um-channel blocking drug and EDTA inhibited NNKYl-19-induced aggregation. These results indicate that GP I b, GP IIb-IIIa complex and the cyclooxygenase pathway are not involved in NNKYl-19-induced platelet activation, that the target of NNKYl-19 on the platelet membrane is same as that of TXA2, and that the mechanism of activation by NNKYl-19 is related to calcium flux.
APA, Harvard, Vancouver, ISO, and other styles
3

Chen, Kui, Laurie Ailles, John E. Dick, and Anand Ghanekar. "Abstract 3476: Profiling CD antigens signature in human hepatocellular carcinoma (HCC) by cell-based high-throughput screening flow cytometry (HTS-FC)." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3476.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Damjanovich, Sandor, Laszlo Balkay, Laszlo Pohubi, Tamas Varhelyi, Laszlo Bene, Adorjan Aszalos, Laszlo Matyus, and Lajos Tron. "Mobility of HLA Class I antigen influenced by anti-CD-4 monoclonal antibody in lymphocyte membranes: a flow cytometric energy transfer, fluorescence photobleaching recovery, and rotational relaxation study." In OE/LASE '90, 14-19 Jan., Los Angeles, CA, edited by Joseph R. Lakowicz. SPIE, 1990. http://dx.doi.org/10.1117/12.17744.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hwang, Sujin, Heba Degheidy, Mondona McCann, Steven Bauer, Raj Puri, and Bharat Joshi. "344 Comparative assessment of product quality attributes associated with production of chimeric antigen receptor T cells expressing scFv CD-19 and scFv IL-13Ra2 by two manufacturing platforms." In SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.0344.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ranu, Harpreet, Omar Jallow, Yanwen Hou, Gary Coulton, and Brendan Madden. "New Insights Into Pulmonary Hypertension Associated With Sickle Cell Disease-A Role For CD 40 Antigen, Tumour Necrosis Factor Receptor Like 2, Heart-Type Fatty Acid Binding Protein And Beta 2 Microglobulin." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1989.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography